Trial · NCT07434934
Augmented Reality-Based Dual-Task Training in People With Multiple Sclerosis
NCT07434934, Not applicable, Not yet recruiting, University of Sharjah
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Augmented Reality-Based Dual-Task Training in People With Multiple Sclerosis. Trials, record NCT07434934. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07434934
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Augmented Reality-Based Dual-Task Training in People With Multiple Sclerosis
- NCT number
- NCT07434934
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- University of Sharjah
- Conditions
- Multiple Sclerosis
- Interventions
- Augmented Reality Exercises
- First posted
- 2026-02-27
- Last updated
- 2026-05-05
Source ClinicalTrials.gov
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Gait Velocity- single-task (BTS GAITLAB) | six weeks | Measured using BTS GAITLAB (Physiotherapy Laboratory, University of Sharjah) during walking under single-task condition (walking only). Report mean gait velocity across trials. Higher = faster walking. |
| Primary | Gait velocity during dual-task walking (m/s) | 6 weeks | Measured using BTS GAITLAB during walking under dual-task cognitive condition. Report mean gait velocity across trials. Higher = faster walking under dual-task. |
| Secondary | Balance - Berg Balance Scale (BBS) | Six weeks | Balance assessed using the Berg Balance Scale. Report total score (0-56). Higher = better balance. |
| Secondary | Activities-specific Balance Confidence (ABC) Scale score (0-100%) | 6 weeks | Balance confidence assessed using the ABC scale. Report total/mean percentage score (0-100%). Higher = greater confidence. |
| Secondary | Five Times Sit-to-Stand test time (seconds) | 6 weeks | Functional lower-limb performance assessed using five times chair sit-to-stand test. Report completion time in seconds. Lower = better. |
| Secondary | Functional Mobility Scale (FMS) rating | 6 weeks | Functional mobility assessed using the Functional Mobility Scale. Report FMS rating (per standard scoring). Higher = better mobility. |
| Secondary | Biodex Balance System stability index (unit per device output) | 6 weeks | Instrumented balance assessed using the Biodex Medical Balance System (Physiotherapy Laboratory, University of Sharjah). Report stability index as provided by the device. Interpret direction as per device metric (lower = better stability). |
| Secondary | Daily step count measured by FIBION (steps/day) | 6 weeks | Physical activity assessed using FIBION activity monitor worn 7 consecutive days / 24 h before and after intervention. Report mean daily step count over the monitoring period. Higher = more activity. |
| Secondary | Modified Physical Activity Scale (M-PAS) score | 6 weeks | Self-reported physical activity assessed using M-PAS. Report total score (per instrument scoring). Specify direction per scoring (higher = more activity). |
| Secondary | Falls Efficacy Scale-International (FES-I) total score | 6 weeks | Fall concern assessed using FES-I. Report total score (per instrument scoring). Higher = greater concern about falling (worse). |
1 to 10 of 20Source ClinicalTrials.gov
See all 20 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Symbol Coding | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07434934
GET https://conductscience.org/api/trials/v1/NCT07434934/registered